Clinical trial
V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants…
NCT00258154 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00258154 |
|---|---|
| Title | V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010) |
| Official title | Safety and Immunogenicity of Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rotavirus Disease |
| Intervention type | Biological |
| Interventions | Rotavirus Vaccine, Live, Oral, Pentavalent, Comparator: placebo, Comparator: Infanrix(tm) Hexa |
| Enrollment | 403 |
| Start date | Feb 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Nov 24, 2005 |
| Last update posted | Oct 6, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: